Gastric cancer, colorectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria:
Exclusion criteria
Exclusion criteria: 1) Treatment with anticoagulants, dextran, thrombolytics, or antiplatelet agents within the past week. 2) Active bleeding 3) Thrombocytopenia 4) Disorders associated with an increased risk of bleeding, such as gastrointestinal tract ulcers, diverticulitis, colitis, acute bacterial endocarditis, severe uncontrolled hypertension, or severe uncontrolled diabetes mellitus 5) Severe hepatic dysfunction (Child class C) 6) A known history of hypersensitivity to unfractionated heparins, low-molecular-weight heparins, or heparinoids; a history of intracranial bleeding 7) A history of surgical intervention of the central nervous system or ocular surgery within the past 3 months; severe renal dysfunction, defined as a creatinine clearance of <20 ml/min; a history of major orthopedic, abdominal, or cardiovascular surgery within the past 3 months; clinical signs of VTE 8) A history of arterial thromboembolism 9) Drug abuse or alcohol dependence 10) Another elective surgical intervention during the study period 11) Pregnancy or lactation; and deemed by the attending physician as unfit for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety assessment of Fondaparinux sodium and intermittent pneumatic compression for laparoscopic surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Identify the incidence of VTE in Japanese patients undergoing laparoscopic surgery 2) Identify the risk factors for VTE | — |
Countries
Japan
Contacts
Kyushu University Department of Surgery and Science,